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Abstract
Multidrug transporters mediate the active extrusion of antibiotics and toxic ions from the
cell. This reaction is thought to be based on a switch of the transporter between two confor-
mational states, one in which the interior substrate binding cavity is available for substrate
binding at the inside of the cell, and another in which the cavity is exposed to the outside of
the cell to enable substrate release. Consistent with this model, cysteine cross-linking stud-
ies with the Major Facilitator Superfamily drug/proton antiporter LmrP from Lactococcus
lactis demonstrated binding of transported benzalkonium to LmrP in its inward-facing state.
The fluorescent dye Hoechst 33342 is a substrate for many multidrug transporters and is
extruded by efflux pumps in microbial and mammalian cells. Surprisingly, and in contrast to
other multidrug transporters, LmrP was found to actively accumulate, rather than extrude,
Hoechst 33342 in lactococcal cells. Consistent with this observation, LmrP expression was
associated with cellular sensitivity, rather than resistance to Hoechst 33342. Thus, we dis-
covered a hidden “Janus” amongst LmrP substrates that is translocated in reverse direction
across the membrane by binding to outward-facing LmrP followed by release from inward-
facing LmrP. These findings are in agreement with distance measurements by electron
paramagnetic resonance in which Hoechst 33342 binding was found to stabilize LmrP in its
outward-facing conformation. Our data have important implications for the use of multidrug
exporters in selective targeting of “Hoechst 33342-like” drugs to cells and tissues in which
these transporters are expressed.
Introduction
Drug transporters play a vital role in the intrinsic and acquired resistance of microorganisms
against antibiotics and cytotoxic agents [1–3]. Some of these drug transporters are rather spe-
cific for a drug or class of drugs, whereas others recognize a wide range of structurally diverse
substrates. Bacterial multidrug transporters fall into 5 protein families of which the Major
Facilitator Superfamily (MFS) is the largest [4]. The 408-amino-acid MFS member LmrP from
Lactococcus lactis functions as a drug-proton antiporter that utilizes both the membrane
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potential (interior negative) and the chemical proton gradient (interior alkaline) of the proton-
motive force to mediate the efflux of amphiphilic substrates from the cell [5–8]. Evidence for
the proton-motive force-dependent transport of drugs, independent of any other accessory
proteins, was provided in studies in proteoliposomes containing purified and functionally
reconstituted protein in which ion gradients were imposed artificially [9,10].
One typical LmrP substrate is the fluorescent dye Hoechst 33342. In aqueous solution,
Hoechst 33342 is essentially non-fluorescent, whereas its partitioning in the membrane and
binding to DNA are associated with a remarkable enhancement of the fluorescence intensity
[11]. LmrP-mediated Hoechst 33342 transport has mostly been studied in inside-out mem-
brane vesicles in which transport from the membrane to the aqueous buffer is associated with a
decrease in fluorescence [12]. The transport reaction in membrane vesicles is inhibited by
other LmrP substrates: competitively in the presence of quinine and verapamil, non-competi-
tively by nicardipin and vinblastin, and un-competitively by tetraphenylphosphonium ions
[12]. This finding suggested that LmrP has multiple drug binding sites, which would explain its
ability to transport drugs belonging to different classes of antibiotics including lincosamides,
macrolides, streptogramins, and tetracyclines [13]. LmrP is predicted to contain a large internal
substrate-binding cavity that contains catalytic carboxylates on its surface: D235 and E327 are
located in the apex, and D142 is located at a side [6]. All three carboxylates can function as pro-
ton binding sites, whereas D235 and E327 have also been implicated in the binding of the diva-
lent cationic substrates Ca2+ and propidium [7,9]. Residues Asp 128 and Asp 68, located in
cytosolic loops outside the internal cavity were also shown to be involved in the proton motive
force-mediated change of LmrP’s accessibility for substrates [14].
Using cysteine cross-linking techniques with a cysteine-less LmrP mutant containing I34C
in the N-terminal half and V240C in the C-terminal half, evidence was obtained that the pro-
tein can switch between at least two major conformational states that are interconverted by the
movement of both halves of the transporter, i.e., the inward-facing conformation in which
I34C and V240C are in close proximity and can interact with each other, and the outward-fac-
ing conformation in which these cysteines are too far apart for cross-linking [8]. Using this
method, it was found that the binding of the transport substrate benzalkonium to LmrP stabi-
lizes the protein in the inward-facing conformation in which the binding cavity is opened to
the inside of the cell. However, more recently, measurements of intramolecular distances in
LmrP by electron paramagnetic resonance (EPR) techniques suggested that the binding of
Hoechst 33342 to LmrP stabilizes the protein in the outward-facing conformation, and ques-
tioned the relevance of an inward-facing conformation for drug binding in the transport cycle
of LmrP [15].
The paradigm in these and related studies has always been that fluorescent dyes such as
ethidium, propidium and Hoechst 33342 are expelled from the cell by LmrP by active efflux.
Here, we studied Hoechst 33342 transport by LmrP in more detail, and conclude that the direc-
tion of transport is reversed in cells compared to that of other dyes. The active uptake of
Hoechst 33342 provides a connecting explanation for the recent hypotheses on LmrP’s trans-
port cycle.
Methods
Bacterial strains, plasmids, and growth conditions
Lactococcus lactis strain NZ9000 ΔlmrA ΔlmrCD [16] harboring the expression vector
pNZ8048 [17] without insert (control) or with the lmrP gene (pHLP5) [5] or lmrCD genes [18]
inserted downstream of the nisin A-inducible promoter [17] were grown at 30°C in M17 broth
(Oxoid Ltd., Basingstoke, UK) supplemented with 25 mM glucose and 5 μg/mL
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chloramphenicol. Cells grown in overnight (< 16 h) cultures were transferred into fresh
medium (1:25 v/v dilution) after which 10 pg/mL nisin A (0.1% v/v of the culture supernatant
of nisin A-producing L. lactis strain NZ9700 [17]) was added when the OD660 had reached
0.55 [8]. After 2 h of nisin-induced protein expression, cells were harvested by centrifugation at
3030 g for 10 min at 4°C.
Hoechst 33342 and ethidium transport in intact cells
For measurements of substrate accumulation in cells that generate metabolic energy (Figs 1A
and 2), cells were washed 3 times in ice-cold 50 mM KPi, 5 mMMgSO4 (pH 7.0) and re-sus-
pended in this buffer to an OD660 of 5.0, and kept on ice. In the transport experiments, the cell
suspensions were diluted in the KPi buffer at 30°C. Glucose (25 mM) was added 3 min before
the addition of 0.1 μMHoechst 33342 (trihydrochloride salt, fluoropure grade, Molecular
Probes, Thermofisher Scientific) or 2 μM ethidium (bromide salt, molecular grade, Promega).
Dye accumulation was monitored by fluorimetry in a Perkin Elmer LS-55B fluorescence spec-
trometer. Hoechst 33342 fluorescence was measured at excitation and emission wavelengths of
355 and 457 nm, respectively, with slit widths of 5 and 10 nm, respectively. For ethidium fluo-
rescence, the excitation and emission wavelengths were set to 500 and 580 nm, respectively,
with slit widths to 5 nm and 10 nm, respectively.
The fluorescence emission of Hoechst 33342 in cells is sensitive to environmental parame-
ters, such as intracellular pH, membrane potential, accessibility of chromosomal DNA and
plasma membrane to Hoechst 33342 binding, and many others. We therefore also measured
the concentration of free Hoechst 33342 in the culture supernatant using standardized condi-
tions. Cells were spun down 9 min after addition of Hoechst 33342 to measure the concentra-
tion of the free dye in the supernatant in a Hoechst 33342-to-DNA binding assay (Fig 1B). The
Fig 1. LmrP accumulates Hoechst 33342 in cells, whereas LmrCD disperses Hoechst 33342 in the extracellular buffer. (A) Lactococcal cells
expressing LmrP, LmrCD, or neither of these proteins (control) were first allowed to generate metabolic energy for 3 min through the addition of 25 mM
glucose before Hoechst 33342 was added at a final concentration of 0.1 μM. Hoechst 33342 transport over time was followed by fluorimetry. Fluorescence
traces represent data obtained in three independent experiments using different batches of cells. (B) The concentration of Hoechst 33342 in the supernatant
of the cell suspensions in (A) at 540 s was measured in triplicate after addition of 1 mg/mL calf thymus DNA, and is presented as mean ± SEM. (*, p < 0.05;
***; p < 0.001; ****, p < 0.0001).
doi:10.1371/journal.pone.0141991.g001
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supernatant was transferred into a sterile tube, to which calf thymus DNA (Trevigen Inc.) was
added to a final concentration of 1 mg/mL. Aliquots (in triplicate) were transferred into wells
of a sterile black 96-well plate. Fluorescence of the Hoechst 33342-DNA complex was mea-
sured in a Spectramax Gemini XS plate reader (with excitation and emission wavelengths of
355 and 457 nm, respectively) and compared with the fluorescence of Hoechst 33342 standards
in a calibration curve. For the calibration curve, calf thymus DNA was diluted in 50 mM KPi
(pH 7.0) supplemented with 5 mMMgSO4 and 25 mM glucose at 20°C. Hoechst 33342 was
added at a final concentration of 0, 0.025, 0.05, 0.075 and 0.1 μM. Aliquots of triplicates of
these dilutions were transferred to wells of a 96-well plate. Data were fitted by linear regression.
To measure dye efflux from preloaded cells (Figs 3A–3C and 4), cells were first ATP-
depleted by washing once with 50 mM KPi (pH 7.0) supplemented with 5 mMMgSO4, and
resuspending in the same KPi buffer containing 0.5 mM 2,4-dinitrophenol (DNP) [19]. Fol-
lowing incubation for 30 min at 30°C, cells were subsequently washed 3 times with ice-cold 50
mM KPi buffer (pH 7.0) containing 5 mMMgSO4, and re-suspended in this buffer to an
OD660 of 5.0 and kept on ice. Cells were pre-loaded at 30°C with 0.1 μMHoechst 33342 or
2 μM ethidium until the fluorescence emission reached a constant level. Glucose (25 mM) was
then added as a source of metabolic energy to assess active substrate efflux. After 15 min of
incubation in the presence of glucose, the cells were spun down in an Eppendorf 5415 D
Fig 2. LmrP expressing cells show reduced accumulation of ethidium compared to control cells. The substrate accumulation experiments described
in Fig 1A were performed with ethidium at a final concentration of 2 μM. Traces represent data obtained in three independent experiments using different
batches of cells.
doi:10.1371/journal.pone.0141991.g002
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centrifuge at 16,168g for 5 min to measure the free Hoechst 33342 concentration in the culture
supernatant (Fig 3D).
All Hoechst 33342 and ethidium transport experiments were performed in triplicate. Figs
1–4 contain representative traces of 3 or more independent experiments using separate batches
of cells. Fluorescence data are normalized to the fluorescence start level at t = 0 s to allow direct
comparisons between different strains. Hoechst 33342 concentrations in the supernatant were
measured in triplicate, and are presented as mean ± SEM. Significance was tested using Welch's
(unpaired) t-test.
Hoechst 33342 sensitivity of cells
Overnight cultures from glycerol stocks of L. lactis strain NZ9000 ΔlmrA ΔlmrCD harboring
the expression vector pNZ8048 without insert (control) and with the lmrP gene (pHLP5) were
grown in M17 containing 25 mM glucose and 5 μg/mL chloramphenicol. Cultures were grown
for about 16 h at 30°C, and then used to inoculate fresh medium for protein production
Fig 3. Active Hoechst 33342 efflux in cells is significant for LmrCD but weak for LmrP. (A-C) ATP-depleted cells with LmrCD (A), LmrP (B) or without
LmrCD or LmrP proteins (control) (C) were preloaded with Hoechst 33342 at a final concentration of 0.1 μM. At the arrow, 25 mM glucose was added to one
aliquot of the cells whereas in the other aliquot the cells remained de-energized. Traces are typical for data obtained in three independent experiments using
different batches of cells. (D) The concentration of Hoechst 33342 (mean ± SEM, n = 3) in the supernatant of the cell suspensions in (A-C) at 900 s was
measured after addition of 1 mg/mL calf thymus DNA. (*, p < 0.05; ***; p < 0.001).
doi:10.1371/journal.pone.0141991.g003
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through the addition of 10 pg/mL nisin at OD660 of 0.55. After 2 h of induction, the cells were
diluted ten-fold in fresh medium containing 10 pg/mL nisin A in the wells of a 96-well plate
after which Hoechst 33342 or ethidium was added as indicated in Fig 5. Growth was followed
over time at OD660 at 30°C in a Versamax microplate reader (Molecular Devices). For the
determination of the relative growth rates of the cultures in each of the wells, the exponential
phase of the growth curve was determined from the linear increase in a 10log(OD660) versus
time plot. The slope of this section was determined by simple linear regression. Heteroscedasti-
city-consistent standard errors of the corresponding slope coefficient were calculated. The
quality of the fit was significant in all cases (P< 0.05). Next, the relative growth rate was deter-
mined as the ratio of the growth rate in the presence of drug over the maximum growth rate in
the absence of drug. The drug concentration that caused a 50% reduction in the relative growth
rate (IC50) was then determined from a plot of the relative growth rate versus drug concentra-
tion (Fig 5).
Fig 4. LmrPmediates active efflux of ethidium. The efflux experiments described in Fig 3 were performed with ethidium at a final concentration of 2 μM.
Traces represent data obtained in three independent experiments using different batches of cells.
doi:10.1371/journal.pone.0141991.g004
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Results
Hoechst 33342 transport was measured in intact cells of L. lactis NZ9000 ΔlmrA ΔlmrCD
expressing LmrP or LmrCD via the NICE expression system [17], and in cells without expres-
sion of these multidrug transporters. Upon addition of Hoechst 33342 at a final concentration
of 0.1 μM to cells in which metabolic energy was generated from glucose catabolism, dye accu-
mulation in LmrCD expressing cells was low compared to control cells indicating active
LmrCD-mediated Hoechst 33342 efflux (Fig 1A). Due to its amphiphilic properties, Hoechst
33342 partitions easily into the cytoplasmic bilayer and from there over time to the inside of
the cell where it binds to DNA with a concomitant fluorescence intensity enhancement [11].
The modestly increasing fluorescence in control cells therefore served as the baseline for pas-
sive Hoechst 33342 influx in the cells. However, the much more rapid and overall higher accu-
mulation of Hoechst 33342 in LmrP expressing cells clearly indicated active LmrP-dependent
influx of the dye.
The fluorescence emission of Hoechst 33342 is greatly enhanced by the partitioning of the
dye in lipid membranes and by its binding to the minor groove in DNA. However, as these
interactions can be altered by protonation and/or deprotonation of the bis-benzimidazole
structure at 5 nitrogen atoms, the level of fluorescence emission by the dye in cells is a multifac-
torial parameter [20]. Therefore, the accumulation of Hoechst 33342 in cells was also evaluated
in a complementary assay based on the measurement under standardized conditions of the
remaining Hoechst 33342 concentration in the culture supernatant (Fig 1B). After 9 min of
incubation with 0.1 μMHoechst 33342, cells were spun down and aliquots of supernatant were
mixed with calf thymus DNA. Fluorescence of the Hoechst 33342-DNA complex was com-
pared with that of Hoechst 33342 standards. The measurements revealed significant differences
in the concentrations of free Hoechst 33342 in the cell suspensions. The concentration of
Hoechst 33342 was the highest in the supernatant of LmrCD expressing cells, which is consis-
tent with the efflux of Hoechst 33342 from these cells. A lower concentration was measured in
the supernatant of control cells, in line with the absence of LmrCD activity. Remarkably, a sig-
nificantly lower concentration than control was found in the supernatant of LmrP expressing
Fig 5. LmrPmediates cellular sensitivity to Hoechst 33342 but resistance to ethidium.Growth rate of LmrP-expressing lactococcal cells and cells
without LmrP expression (control) in the presence of up to 8.4 μMHoechst 33342 (A), or up to 24 μM ethidium (B) was determined relative to the maximum
growth rate in the absence of drug. The error bars for some of the data points were too small to be displayed, and are hidden behind the data point symbols.
doi:10.1371/journal.pone.0141991.g005
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cells, consistent with the enhanced accumulation of the dye in cells containing LmrP (Fig 1A).
Both the measurements of transport and extracellular Hoechst concentrations therefore sug-
gest active LmrP-mediated influx of Hoechst 33342 into lactococcal cells. The transport activity
of LmrP was also tested in the same cell suspensions in a robust ethidium transport assay that
is based on ethidium intercalation in intracellular nucleic acids (Fig 2). Upon addition of 2 μM
ethidium, dye accumulation remained low for LmrP expressing cells whereas control cells rap-
idly accumulated ethidium over time. Consistent with previous publications [6,7], these data
demonstrate LmrP’s ability to catalyze ethidium extrusion.
The ability of LmrP to mediate Hoechst 33342 efflux was tested in ATP-depleted cells in
which Hoechst 33342 was first allowed to accumulate until a steady-state level was reached.
Next, 25 mM glucose was added to the cells to allow the generation of metabolic energy to acti-
vate LmrP activity. The subsequent decrease in Hoechst 33342 fluorescence was most pro-
nounced for LmrCD expressing cells (Fig 3A) but was very weak for LmrP expressing cells (Fig
3B) compared to the control (Fig 3C). The free Hoechst 33342 concentration in the superna-
tant was quantified after a prolonged incubation of 15 min after glucose addition when no fur-
ther decrease in fluorescence could be observed. The same was done for cells without glucose
addition for exactly the same amount of time. A comparison of measured Hoechst 33342 con-
centrations in the supernatant suggested active Hoechst 33342 efflux from LmrP and LmrCD
expressing cells with a significantly greater efflux activity for the latter. The concentration of
Hoechst 33342 in the supernatant of control cells was indistinguishable in the presence or
absence of glucose (Fig 3D). The functionality of LmrP in the ATP-depleted cells was also
tested using ethidium as the substrate. The addition of glucose elicited a robust ethidium efflux
from the ethidium-loaded cells containing LmrP whereas control cells showed an increase in
ethidium fluorescence. The latter can be explained by the stimulation of the passive influx of
ethidium in these cells in response to the rise in the membrane potential (interior negative)
during glucose metabolism (Fig 4).
Finally, the active influx of Hoechst 33342 by LmrP in cells was also observed in growth
experiments in which LmrP expression was associated with a sensitivity for Hoechst 33342
compared to the control (Fig 5A). Here, LmrP expressing cells exhibited an IC50 value of
0.39 ± 0.04 μM as compared to 1.60 ± 0.02 μM for control cells. A similar experiment with
ethidium demonstrated the LmrP-mediated resistance against this dye (Fig 5B). In this case, an
IC50 value of 4.20 ± 0.11 μMwas determined for the control, whereas the IC50 value for LmrP
expressing cells exceeded 24 μM. These data show that LmrP expression confers Hoechst
33342 sensitivity on the lactococcal cells, rather than Hoechst 33342 resistance, whereas for
ethidium the usual resistance is observed.
Discussion
The MFS drug/proton antiporter LmrP confers resistance on lactococcal cells to 22 clinically
used antibiotics [13]. Many antibiotics are amphiphilic compounds that bind to the mem-
brane-water interface with exposure of their hydrophobic moieties to the phospholipid bilayer
and hydrophilic moieties to the aqueous environment [21]. Due to the close alignment of the
acyl chains of the phospholipids and the overall hydrophobicity of this region, the membrane
provides a barrier that limits the rate of passive influx of ions and antibiotics [22]. The cellular
uptake of drugs is facilitated by the presence of cationic moieties that enhance accumulation at
the inside surface of the membrane in response to the transmembrane potential (interior nega-
tive). Detailed studies have shown that LmrP mediates the transbilayer movement of the
amphiphilic cationic substrate TMA-DPH (1-(4-(trimethylamino)phenyl)-6-phenylhexa-
1,3,5-triene) from the inner leaflet of the cytoplasmic membrane to the external side of the cell
Active Hoechst 33342 Uptake by LmrP
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[5], thus effectively facilitating the transbilayer efflux of substrate across a permeability barrier
at a rate that exceeds the rate of passive substrate influx.
Based on crystallographic data for secondary-active membrane transporters, including LacY
and LeuT, these transporters are thought to operate by an alternating mechanism involving at
least an inward-open and outward-open state [23,24] in which conformational transitions are
triggered by the binding and dissociation of substrate and coupling ion(s). This alternating
access mechanism is also likely to be relevant for LmrP, although the sequence of molecular
steps in proton and substrate binding and release, and their relation to the conformational
changes that underlie this mechanism, are not well resolved. For LmrP, two different models
have been proposed to explain drug efflux. Firstly, cysteine cross-linking studies with LmrP
C270S I34C V240C suggest that benzalkonium binding stabilizes a conformation that is
inward-facing (Model 1) [8]; a similar working model was also proposed for the E. coliMFS
multidrug transporter MdfA [25]. During proton-drug antiport, carboxylates in LmrP are pro-
tonated in the outward-facing conformation. This protonation facilitates a chemical proton
gradient-dependent conformational switch to the inward-facing conformation, which allows
(and might also require) substrate binding from the interior of the cell. Proton release at the
inside surface subsequently facilitates a second conformational switch in which dissociated car-
boxylates reorient back to outward-facing in a membrane potential (interior negative)-depen-
dent fashion. The cycle is completed by reprotonation of carboxylates at the external side of the
membrane with concomitant substrate release [8]. Secondly, a previous study on LmrP based
on distance measurements by EPR suggested that Hoechst 33342 binds from the cellular inte-
rior to the outward-facing state, rather than the inward-facing state, and proposed that subse-
quent proton binding coordinates substrate release from this state into the extracellular
environment (Model 2) [15]. Proton movement via acidic residues eventually leads to proton-
ation of Asp68 at the intracellular side of LmrP, which induces closure of LmrP on the extracel-
lular side with concomitant opening on the intracellular side. This opening is thought to lead
to (partial) exposure to the intracellular milieu, allowing for deprotonation of Asp68, at which
point LmrP is thought to re-set to the resting (occluded) state [15]. A new cycle of Hoechst
33342 binding to the outward-facing state can now be initiated.
These two models were developed using experimental procedures that differed methodolog-
ically in the choice of substrates. Whereas the studies leading to Model 1 used benzalkonium
and ethidium as substrates that are known to be effluxed by LmrP via substrate-proton antiport
[8], Model 2 was based on the interaction of LmrP with Hoechst 33342. Our study shows that,
in fact, the addition of Hoechst 33342 to the external side of LmrP-expressing cells results in
active influx of Hoechst 33342. The stabilization of an outward-facing state by Hoechst 33342
but inward-facing state by benzalkonium can now be explained in the light of LmrP’s opposite
direction of transport for these substrates. For each of these, the substrate initially binds to the
transporter at the side of the membrane from where transport is initiated. The uptake of
Hoechst 33342 by LmrP is unexpected, as LmrCD and other multidrug transporters mediate
the efflux of both substrates (see Fig 1). In our experiments, a weak LmrP-mediated efflux of
Hoechst 33342 was only observed after a substantial intracellular pool of the dye was generated
through preloading of the cells (Fig 3B). Our experiments on LmrP-mediated influx of Hoechst
33342 in cells have implications for earlier observations on LmrP-mediated Hoechst 33342
transport in lactococcal inside-out membrane vesicles [12,13], which might reflect transport of
Hoechst 33342 from the membrane to the external buffer rather than the lumen of these mem-
brane vesicles.
Substrate uptake by multidrug transporters is an interesting feature that might be exploited
therapeutically in the future to selectively target cells and tissues in which multidrug transport-
ers are upregulated. We previously studied drug uptake by ATP-binding cassette exporters in
Active Hoechst 33342 Uptake by LmrP
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ATP-depleted cells [19,26]. Our finding of active LmrP-mediated Hoechst 33342 uptake in
cells now extends these observations to an MFS multidrug transporter in cells that generate
metabolic energy.
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